Red Ultraviolet Sunglasses: A Practical Solution for Cognitive Wellness
The Mito Red Light Therapy Glasses IR5 (Extra Dark) are designed to provide eye protection during red light therapy sessions by attenuating red and near-infrared light wavelengths commonly used in LED therapy. This reduction in light exposure helps decrease eye strain while allowing some visible light to pass through.
Good For:
Mito Red Light Therapy Glasses IR5: How Does it Rate?
Pros
- Effective Light Attenuation: Blocks both red and near-infrared light (600nm-900nm), reducing brightness and intensity during therapy sessions.
- Customizable Protection: Available in two levels of attenuation—IR3 Dark (80% reduction) and IR5 Extra Dark (95% reduction)—to suit individual comfort and specific use cases.
- Comfortable Design: Lightweight, anti-scratch glasses designed for comfort and effectiveness, unlike bulkier alternatives.
Cons
- Limited Use Case: Specifically designed for red light therapy; not intended for general eye protection or other activities.
- Visible Light Transmittance: While they reduce red and near-infrared light, they still allow some visible light through, which may not be suitable for users seeking complete darkness.
About the Brand
Mito Red Light is a company specializing in red light therapy products, offering a range of devices and accessories designed to enhance user experience and safety during therapy sessions.
How Do the Mito Red Light Therapy Glasses IR5 Work?
These glasses are engineered to attenuate the most commonly used wavelengths in red light therapy devices, specifically targeting the 600nm-900nm range. By reducing the intensity of red and near-infrared light, they help minimize eye strain and discomfort during therapy sessions while still allowing some visible light to pass through.
Benefits of Using Mito Red Light Therapy Glasses IR5:
Eye Protection: Shields eyes from intense red and near-infrared light, reducing the risk of eye strain.
Enhanced Comfort: Allows users to undergo red light therapy sessions more comfortably by decreasing light intensity.
Improved Therapy Experience: By reducing discomfort, users may find it easier to maintain regular therapy sessions, potentially enhancing overall benefits.
Quick Facts & Features
| Brand | Mito Red Light |
|---|---|
| Product | Mito Red Light | Red Light Therapy Glasses IR5 (Extra Dark) |
| Form | Wearable glasses |
| Wavelength Attenuation | 600nm-900nm |
| Attenuation Levels | IR3 Dark (80% reduction) and IR5 Extra Dark (95% reduction) |
| Safety | FDA-Cleared |
| Age | Any |
| Skin Type | All types |
| Benefit | Cognitive Function, Memory, Depression, Brain Health etc |
| Price | $12.95 |
| Shipping | Free Shipping |
| Warranty | 1-Year Warranty |
| Purchase | Official website |
How to Use It?
Wear During Therapy: Put on the glasses before starting your red light therapy session to protect your eyes from the light exposure.
Select Appropriate Attenuation: Choose between IR3 or IR5 based on your comfort and the intensity of your therapy device.
Maintain Cleanliness: Keep the glasses clean and free from scratches to ensure optimal performance.
Safety
The glasses are designed to provide targeted protection during red light therapy sessions. They are not intended for use as general safety glasses or for protection against other types of light or radiation.
Side Effects
There are no known side effects associated with using these glasses as directed during red light therapy sessions.
Reviews From Users
Users have reported that the Mito Red Light Therapy Glasses IR5 effectively reduce eye strain during therapy sessions and are comfortable to wear. The lightweight design and choice of attenuation levels have been highlighted as positive features
— HealthNews Review.
— S. Marie – Verified Buyer
— Allison B. – Verified Buyer
Frequently Asked Questions
What is the NeuroWrap?
The NeuroWrap is a device designed to deliver transcranial red light therapy, leveraging specific light wavelengths to potentially support brain cell function and promote neurological health.
What are the Mito Red Light Therapy Glasses IR5?
They are protective eyewear designed to attenuate red and near-infrared light during red light therapy sessions, reducing eye strain while allowing some visible light through.
How do the Mito Red Light Therapy Glasses IR5 work?
The glasses block 95% of red and near-infrared light in the 600nm-900nm range, decreasing light intensity and brightness during therapy sessions.
Can I use the Mito Red Light Therapy Glasses IR5 for other activities?
No, these glasses are specifically designed for red light therapy sessions and are not intended for general eye protection or other activities.
Are there different levels of attenuation available?
Yes, Mito Red Light offers two levels of attenuation: IR3 Dark (80% reduction) and IR5 Extra Dark (95% reduction).
How should I maintain the glasses?
Keep the glasses clean and free from scratches to ensure optimal performance. Use a soft cloth to clean the lenses and store them in a protective case when not in use.
Conclusion
The Mito Red Light Therapy Glasses IR5 (Extra Dark) offer effective eye protection for individuals undergoing red light therapy. With high levels of attenuation and a comfortable design, they enhance the therapy experience by reducing eye strain and discomfort. Priced at $12.95, they provide a cost-effective solution for those seeking specialized eye protection during red light therapy sessions.
For more information or to purchase the Mito Red Light Therapy Glasses IR5, visit the official product page.
Red light therapy is a type of therapy that uses red or near-infrared light to treat a variety of conditions. During a red light therapy session, a person is exposed to a specific wavelength of red or near-infrared light that is delivered through a light-emitting device. The light penetrates the skin and reaches the cells within the body with a range of therapeutic effects.
Red light is a type of visible light, Its wavelength falls between approximately 630 and 700 nanometers (nm) on the electromagnetic spectrum. Red light is often used in light therapy treatments for the skin, as it has been shown to have the most beneficial effects on skin cells and collagen production.
Near-infrared (NIR) light, on the other hand, has a longer wavelength than visible red light and falls between approximately 700 and 1200 nm on the electromagnetic spectrum. NIR light is not visible to the human eye, but it can penetrate deeper into the skin and other tissues than visible light, making it useful for a variety of therapeutic applications ranging from wound healing to inflammation reduction or improved circulation, among other benefits.
Different Red Light Therapy devices usually deliver slightly different wavelength ranges that research has shown to be the most effective for the concern they are being recommended for.
Red Light Therapy (RLT) strengthens the mitochondria, the cell’s powerhouse, where cell energy is created. Adenosine Triphosphate (ATP) is the critical energy-carrying molecule that is found in all living organisms. By optimizing the function of the mitochondria, more ATP is produced and with increased energy cells can function optimally.
This scientific breakthrough resulted in scientists discovering Red Light Therapy’s ability to stimulate and speed up tissue repair and growth. Red Light Therapy is now widely used for maintaining a healthy complexion, speeding up muscle recovery, reducing inflammation, improving sleep, treating neurological conditions, balancing hormones, treating pain, and even losing weight.
Research has also indicated that Red Light Therapy can help to restore cellular balance and alleviate the negative impact of blue light exposure. The prevalence of blue light in our society has become a growing concern as many individuals spend prolonged periods of time looking at screens on a daily basis.
Red Light Therapy (RLT) is also called:
Low-Level Light Therapy (LLLT), Photobiomodulation (PBM), Cold Laser Therapy, Photonic Stimulation, Low-Power Laser Therapy (LPLT), Phototherapy
A Brief History of Red Light Therapy
The journey of Red Light Therapy (RLT) has been both fascinating and impactful, starting from its humble origins in the late 19th century. Dr. Niels Ryberg Finsen, the pioneer in light therapy, made a groundbreaking discovery in 1896 that light could be harnessed to treat Lupus Vulgaris, a form of tuberculosis affecting the skin. His work, which led to the tangible healing of skin lesions, was so revolutionary that he received the Nobel Prize in Physiology in 1903.
Fast forward to 1960, Theodore H. Maiman invented the first operational laser, fulfilling Albert Einstein's theories on the principles of lasers laid out in 1917. This invention opened new avenues for RLT, allowing more precise applications.
NASA took an interest in Red Light Therapy in 1987, conducting experiments to examine its effects on plant growth in space missions. These studies hinted at RLT's potential to benefit not just human health but also broader ecological systems.
In the same vein, Endre Mester's work in 1967 set the stage for modern RLT applications.
His experimentation with low-level laser therapy on skin cancer effects demonstrated the technique's efficacy and led to FDA approval for wound healing in 2002.
The advent of LED technology in the 1990s was a game-changer, offering an efficient and cost-effective alternative to traditional light bulbs. This technological leap made light therapy more accessible to the general public, including its use in sports medicine where physical therapists reported quicker recovery times for sports-related injuries.
One of the most recent and exciting developments in RLT is its potential role in weight management. Studies indicate that Red Light Therapy can influence hormones like Leptin and Ghrelin, which play key roles in regulating appetite and metabolism. This makes RLT a promising avenue for non-invasive weight loss treatments.
As RLT continues to evolve, its applications keep expanding, crossing multiple disciplines from medicine to ecology. Researchers are continuously probing its potential, finding new ways to apply this age-old yet ever-advancing technology.
Our articles exclusively rely on primary sources of information, encompassing peer-reviewed medical journals and esteemed academic institutions.
- NASA. (2022, May 19). NASA Research Illuminates Medical Uses of Light. https://spinoff.nasa.gov/NASA-Research-Illuminates-Medical-Uses-of-Light
- American Association of Neurological Surgeons. (2023). Anatomy of the Brain. https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Anatomy-of-the-Brain
- Gulati, A. (2015). Understanding neurogenesis in the adult human brain. Indian Journal of Pharmacology, 47(6), 583-584. https://doi.org/10.4103/0253-7613.169598
- Adolphs, R. (2009). The social brain: Neural basis of social knowledge. Annual Review of Psychology, 60, 693-716. https://doi.org/10.1146/annurev.psych.60.110707.163514
- Wang, Y., Pan, Y., & Li, H. (2020). What is brain health and why is it important? BMJ, 371, m3683. https://doi.org/10.1136/bmj.m3683
- Breijyeh, Z., & Karaman, R. (2020). Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules, 25(24), 5789. https://doi.org/10.3390/molecules25245789
- DeMaagd, G., & Philip, A. (2015). Parkinson’s disease and its management: Part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T, 40(8), 504-510. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517533/
- American Association of Neurological Surgeons. (2023). Parkinson’s Disease. https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Parkinsons-Disease
- Kuriakose, D., & Xiao, Z. (2020). Pathophysiology and treatment of stroke: Present status and future perspectives. International Journal of Molecular Sciences, 21(20), 7609. https://doi.org/10.3390/ijms21207609
- Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. (2023, April 20). Traumatic Brain Injury & Concussion (TBI). https://www.cdc.gov/traumaticbraininjury/get_the_facts.html
- Lacerte, M., Shapshak, A. H., & Mesfin, F. B. (2023). Hypoxic Brain Injury. StatPearls [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK537310/
- World Health Organization. (2022, August 9). Optimizing brain health across the life course: WHO position paper. https://www.who.int/publications/i/item/9789240054561
- Bischof, G. N., & Park, D. C. (2015). Obesity and Aging: Consequences for Cognition, Brain Structure and Brain Function. Psychosomatic Medicine, 77(6), 697–709. https://doi.org/10.1097/PSY.0000000000000212
- Tafur, J., & Mills, P. J. (2008). Low-Intensity Light Therapy: Exploring the Role of Redox Mechanisms. Photomedicine and Laser Surgery, 26(4), 323–328. https://doi.org/10.1089/pho.2007.2184
- Wunsch, A., & Matuschka, K. (2014). A Controlled Trial to Determine the Efficacy of Red and Near-infrared Light Treatment in Patient Satisfaction, Reduction of Fine Lines, Wrinkles, Skin Roughness, and Intradermal Collagen Density Increase. Photomedicine and Laser Surgery, 32(2), 93–100. https://doi.org/10.1089/pho.2013.3616
- ampl, Y., Zivin, J. A., Fisher, M., Lew, R., Welin, L., Dahlof, B., . . . Oron, U. (2007). Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy Results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke, 38, 1843-1849. https://doi.org/10.1161/STROKEAHA.106.478230
- Giacci, M. K., Wheeler, L., Lovett, S., Dishington, E., Majda, B., Bartlett, C. A., . . . Fitzgerald, M. (2014). Differential Effects of 670 and 830 nm Red near Infrared Irradiation Therapy: A Comparative Study of Optic Nerve Injury, Retinal Degeneration, Traumatic Brain and Spinal Cord Injury. PLOS ONE. https://doi.org/10.1371/journal.pone.0104565
- Johnstone, D. M., Moro, C., Stone, J., Benabid, A.-L., & Mitrofanis, J. (2016). Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease. Frontiers in Neuroscience, 9, 500. https://doi.org/10.3389/fnins.2015.00500
- Naeser, M. A., Zafonte, R., Krengel, M. H., Martin, P. I., Frazier, J., Hamblin, M. R., Knight, J. A., Meehan, W. P., Baker, E. H. (2014). Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study. Journal of Neurotrauma, 31(11),1008-17. https://doi.org/10.1089/neu.2013.3244
- U.S. Department of Veterans Affairs. (2015, March 31). Can light therapy help the brain? VA study with 160 Gulf War Veterans will test red, near-infrared light. Office of Research & Development. https://www.research.va.gov/currents/spring2015/spring2015-7.cfm
- Hipskind, S. G., Grover, F. L., Fort, T. R., Helffenstein, D., Burke, T. J., Quint, S. A., Bussiere, G., Stone, M., & Hurtado, T. (2018). Pulsed Transcranial Red/Near-Infrared Light Therapy Using Light-Emitting Diodes Improves Cerebral Blood Flow and Cognitive Function in Veterans with Chronic Traumatic Brain Injury: A Case Series. Photomedicine and Laser Surgery. https://doi.org/10.1089/pho.2018.4489
- Hamblin, M. R. (2016). Shining light on the head: Photobiomodulation for brain disorders. BBA Clinical, 6, 113-124. https://doi.org/10.1016/j.bbacli.2016.09.002
- Hamblin, M. R. (2017). Photobiomodulation for traumatic brain injury and stroke. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.24190
- Huang, N., Yao, D., Jiang, W., Wei, C., Li, M., Li, W., . . . Tong, Z. (2020). Safety and Efficacy of 630-nm Red Light on Cognitive Function in Older Adults With Mild to Moderate Alzheimer’s Disease: Protocol for a Randomized Controlled Study. Frontiers in Aging Neuroscience, 12, 143. https://doi.org/10.3389/fnagi.2020.00143
- Foo, A. S. C., Soong, T. W., Yeo, T. T., & Lim, K. L. (2020). Mitochondrial Dysfunction and Parkinson’s Disease—Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy. Frontiers in Aging Neuroscience, 12. https://doi.org/10.3389/fnagi.2020.00089
- Yang, M., Yang, Z., Wang, P., & Sun, Z. (2020). Current application and future directions of photobiomodulation in central nervous diseases. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.30048
- Liu, Y., Gong, S., Xia, S., Wang, Y., Peng, H., Shen, Y., & Liu, C. (2021). Light therapy: a new option for neurodegenerative diseases. Chinese Medical Journal, 134(6), 634-645. https://doi.org/10.1097/CM9.0000000000001301
- Hamilton, C., Liebert, A., Pang, V., Magistretti, P., & Mitrofanis, J. (2022). Lights on for autism: Exploring photobiomodulation as an effective therapeutic option. Neurology International, 14(4), 884-893. https://doi.org/10.3390/neurolint14040071
- Nizamutdinov, D., Ezeudu, C., Wu, E., Huang, J. H., & Yi, S. S. (2022). Transcranial near-infrared light in treatment of neurodegenerative diseases. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.965788
- Torres-Martinez, N., Chabardes, S., & Mitrofanis, J. (2023). Lights for epilepsy: can photobiomodulation reduce seizures and offer neuroprotection? Neural Regeneration Research, 18(7), 1423-1426. https://doi.org/10.4103/1673-5374.360288
- Berman, M. H., Halper, J. P., Nichols, T. W., Jarrett, H., Lundy, A., & Huang, J. H. (2017). Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition. Journal of Neurology and Neuroscience, 8(1). https://doi.org/10.21767/2171-6625.1000176
- Hu, D., Moalem-Taylor, G., & Potas, J. R. (n.d.). Red-light (670 nm) therapy reduces mechanical sensitivity and neuronal cell death, and alters glial responses following spinal cord injury in rats. Journal of Neurotrauma. https://doi.org/10.1089/neu.2020.7066
- Dmochowski, G. M., Shereen, A. D., Berisha, D., & Dmochowski, J. P. (2020). Near-infrared light increases functional connectivity with a non-thermal mechanism. Cerebral Cortex Communications, 1(1), tgaa004. https://doi.org/10.1093/texcom/tgaa004
- [34] Figueiro Longo, M. G., Tan, C. O., Chan, S., Welt, J., Avesta, A., Ratai, E., Mercaldo, N. D., Yendiki, A., Namati, J., Chico-Calero, I., Parry, B. A., Drake, L., Anderson, R., Rauch, T., Diaz-Arrastia, R., Lev, M., Lee, J., Hamblin, M., Vakoc, B., & Gupta, R. (2020). Effect of transcranial low-level light therapy vs sham therapy among patients with moderate traumatic brain injury: A randomized clinical trial. JAMA Network Open, 3(9), e2017337. https://doi.org/10.1001/jamanetworkopen.2020.17337
- Jara, C., Buendía, D., Ardiles, A., Muñoz, P., & Tapia-Rojas, C. (2021). Transcranial Red LED Therapy: A Promising Non-Invasive Treatment to Prevent Age-Related Hippocampal Memory Impairment. Hippocampus: Cytoarchitecture and Diseases. https://doi.org/10.5772/intechopen.100620
- Liebert, A., Bicknell, B., Laakso, E. L., Heller, G., Jalilitabaei, P., Tilley, S., Mitrofanis, J., & Kiat, H. (2021). Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study. BMC Neurology, 21, 256. https://doi.org/10.1186/s12883-021-02248-y
- Nizamutdinov, D., Qi, X., Berman, M. H., Dougal, G., Dayawansa, S., Wu, E., Yi, S. S., Stevens, A. B., & Huang, J. H. (2021). Transcranial Near Infrared Light Stimulations Improve Cognition in Patients with Dementia. Aging and Disease, 12(4), 954–963. https://doi.org/10.14336/AD.2021.0229
- Dougal, G., Ennaceur, A., & Chazot, P. L. (2021). Effect of Transcranial Near-Infrared Light 1068 nm Upon Memory Performance in Aging Healthy Individuals: A Pilot Study. Photobiomodulation, Photomedicine, and Laser Surgery, 39(10). https://doi.org/10.1089/photob.2020.4956
- Stepanov, Y. V., Golovynska, I., Zhang, R., Golovynskyi, S., Stepanova, L. I., Gorbach, O., Dovbynchuk, T., Garmanchuk, L. V., Ohulchanskyy, T. Y., & Qu, J. (2022). Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer’s disease. Alzheimer's Research & Therapy, 14, 84. https://doi.org/10.1186/s13195-022-01022-7
